Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04967469Completed
Trial of calcitriol and alfacalcidol in secondary hyperparathyroidism (SHPT), sponsored by Ministry of Public Health. Primary endpoint: Serum Calcium at 4 years. Started Sep 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04967469.